nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Thalidomide—leprosy	0.24	0.508	CbGbCtD
Rizatriptan—CYP1A2—Rifampicin—leprosy	0.232	0.492	CbGbCtD
Rizatriptan—HTR1F—trigeminal nerve—leprosy	0.0877	0.329	CbGeAlD
Rizatriptan—HTR1B—trigeminal nerve—leprosy	0.0359	0.135	CbGeAlD
Rizatriptan—HTR1D—trigeminal nerve—leprosy	0.0348	0.131	CbGeAlD
Rizatriptan—HTR1B—cranial nerve—leprosy	0.0256	0.0961	CbGeAlD
Rizatriptan—HTR1D—cranial nerve—leprosy	0.0248	0.093	CbGeAlD
Rizatriptan—Hangover—Thalidomide—leprosy	0.0156	0.0596	CcSEcCtD
Rizatriptan—HTR1B—blood vessel—leprosy	0.0103	0.0387	CbGeAlD
Rizatriptan—HTR1D—blood vessel—leprosy	0.00998	0.0374	CbGeAlD
Rizatriptan—MAOA—nerve—leprosy	0.00968	0.0363	CbGeAlD
Rizatriptan—Dysaesthesia—Thalidomide—leprosy	0.00848	0.0325	CcSEcCtD
Rizatriptan—Hyporeflexia—Thalidomide—leprosy	0.00807	0.0309	CcSEcCtD
Rizatriptan—HTR1F—nervous system—leprosy	0.00721	0.027	CbGeAlD
Rizatriptan—Menstrual disorder—Thalidomide—leprosy	0.00538	0.0206	CcSEcCtD
Rizatriptan—HTR1D—eye—leprosy	0.00531	0.0199	CbGeAlD
Rizatriptan—Hyperaesthesia—Thalidomide—leprosy	0.00467	0.0179	CcSEcCtD
Rizatriptan—Nasopharyngitis—Dapsone—leprosy	0.00465	0.0178	CcSEcCtD
Rizatriptan—Muscular weakness—Dapsone—leprosy	0.00459	0.0176	CcSEcCtD
Rizatriptan—Myocardial ischaemia—Thalidomide—leprosy	0.00456	0.0175	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Dapsone—leprosy	0.0041	0.0157	CcSEcCtD
Rizatriptan—Musculoskeletal stiffness—Thalidomide—leprosy	0.00409	0.0157	CcSEcCtD
Rizatriptan—Hearing impaired—Thalidomide—leprosy	0.00385	0.0148	CcSEcCtD
Rizatriptan—Gait disturbance—Thalidomide—leprosy	0.00376	0.0144	CcSEcCtD
Rizatriptan—Coordination abnormal—Thalidomide—leprosy	0.00373	0.0143	CcSEcCtD
Rizatriptan—Neck pain—Thalidomide—leprosy	0.00371	0.0142	CcSEcCtD
Rizatriptan—Eructation—Thalidomide—leprosy	0.0036	0.0138	CcSEcCtD
Rizatriptan—Pharyngitis—Dapsone—leprosy	0.00357	0.0137	CcSEcCtD
Rizatriptan—Dry eye—Thalidomide—leprosy	0.00339	0.013	CcSEcCtD
Rizatriptan—Tinnitus—Dapsone—leprosy	0.00335	0.0129	CcSEcCtD
Rizatriptan—Hyperkinesia—Thalidomide—leprosy	0.0032	0.0123	CcSEcCtD
Rizatriptan—Euphoric mood—Thalidomide—leprosy	0.00315	0.0121	CcSEcCtD
Rizatriptan—Erythema—Dapsone—leprosy	0.00313	0.012	CcSEcCtD
Rizatriptan—Photosensitivity—Thalidomide—leprosy	0.00303	0.0116	CcSEcCtD
Rizatriptan—Deafness—Thalidomide—leprosy	0.00298	0.0114	CcSEcCtD
Rizatriptan—HTR1B—nervous system—leprosy	0.00295	0.0111	CbGeAlD
Rizatriptan—Vision blurred—Dapsone—leprosy	0.00295	0.0113	CcSEcCtD
Rizatriptan—Eye pain—Thalidomide—leprosy	0.00295	0.0113	CcSEcCtD
Rizatriptan—HTR1D—nervous system—leprosy	0.00286	0.0107	CbGeAlD
Rizatriptan—Increased appetite—Thalidomide—leprosy	0.00283	0.0109	CcSEcCtD
Rizatriptan—Vertigo—Dapsone—leprosy	0.00281	0.0108	CcSEcCtD
Rizatriptan—Cough—Dapsone—leprosy	0.00273	0.0105	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Thalidomide—leprosy	0.00272	0.0104	CcSEcCtD
Rizatriptan—MAOA—tendon—leprosy	0.00268	0.01	CbGeAlD
Rizatriptan—Osteoarthritis—Thalidomide—leprosy	0.00266	0.0102	CcSEcCtD
Rizatriptan—Face oedema—Thalidomide—leprosy	0.00257	0.00985	CcSEcCtD
Rizatriptan—Ataxia—Thalidomide—leprosy	0.0025	0.00959	CcSEcCtD
Rizatriptan—Tachycardia—Dapsone—leprosy	0.00249	0.00956	CcSEcCtD
Rizatriptan—Dehydration—Thalidomide—leprosy	0.00248	0.00949	CcSEcCtD
Rizatriptan—Cramp muscle—Thalidomide—leprosy	0.0024	0.00918	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0024	0.00918	CcSEcCtD
Rizatriptan—HTR1A—nervous system—leprosy	0.00238	0.00893	CbGeAlD
Rizatriptan—Muscular weakness—Thalidomide—leprosy	0.00235	0.009	CcSEcCtD
Rizatriptan—Abdominal distension—Thalidomide—leprosy	0.00232	0.00887	CcSEcCtD
Rizatriptan—Insomnia—Dapsone—leprosy	0.00231	0.00886	CcSEcCtD
Rizatriptan—Dysphagia—Thalidomide—leprosy	0.0023	0.00882	CcSEcCtD
Rizatriptan—Angina pectoris—Thalidomide—leprosy	0.00224	0.00859	CcSEcCtD
Rizatriptan—MAOA—testis—leprosy	0.00222	0.00832	CbGeAlD
Rizatriptan—MAOA—nervous system—leprosy	0.00218	0.00816	CbGeAlD
Rizatriptan—Upper respiratory tract infection—Thalidomide—leprosy	0.00214	0.00819	CcSEcCtD
Rizatriptan—Pollakiuria—Thalidomide—leprosy	0.00213	0.00814	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Thalidomide—leprosy	0.0021	0.00805	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dapsone—leprosy	0.00209	0.00801	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Thalidomide—leprosy	0.00202	0.00775	CcSEcCtD
Rizatriptan—Abdominal pain—Dapsone—leprosy	0.00202	0.00774	CcSEcCtD
Rizatriptan—Body temperature increased—Dapsone—leprosy	0.00202	0.00774	CcSEcCtD
Rizatriptan—Myocardial infarction—Thalidomide—leprosy	0.00201	0.0077	CcSEcCtD
Rizatriptan—Sweating—Thalidomide—leprosy	0.00197	0.00754	CcSEcCtD
Rizatriptan—Epistaxis—Thalidomide—leprosy	0.00193	0.00741	CcSEcCtD
Rizatriptan—Bradycardia—Thalidomide—leprosy	0.00187	0.00718	CcSEcCtD
Rizatriptan—Hypoaesthesia—Thalidomide—leprosy	0.00183	0.00702	CcSEcCtD
Rizatriptan—Pharyngitis—Thalidomide—leprosy	0.00183	0.007	CcSEcCtD
Rizatriptan—Tinnitus—Thalidomide—leprosy	0.00172	0.00658	CcSEcCtD
Rizatriptan—Angiopathy—Thalidomide—leprosy	0.00167	0.0064	CcSEcCtD
Rizatriptan—Chills—Thalidomide—leprosy	0.00165	0.00633	CcSEcCtD
Rizatriptan—Arrhythmia—Thalidomide—leprosy	0.00165	0.0063	CcSEcCtD
Rizatriptan—Vomiting—Dapsone—leprosy	0.00162	0.00623	CcSEcCtD
Rizatriptan—Mental disorder—Thalidomide—leprosy	0.00161	0.00618	CcSEcCtD
Rizatriptan—Headache—Dapsone—leprosy	0.0016	0.00613	CcSEcCtD
Rizatriptan—Flatulence—Thalidomide—leprosy	0.00158	0.00605	CcSEcCtD
Rizatriptan—Tension—Thalidomide—leprosy	0.00157	0.00603	CcSEcCtD
Rizatriptan—Dysgeusia—Thalidomide—leprosy	0.00157	0.00602	CcSEcCtD
Rizatriptan—Nervousness—Thalidomide—leprosy	0.00156	0.00597	CcSEcCtD
Rizatriptan—Muscle spasms—Thalidomide—leprosy	0.00154	0.00591	CcSEcCtD
Rizatriptan—Nausea—Dapsone—leprosy	0.00152	0.00582	CcSEcCtD
Rizatriptan—Vision blurred—Thalidomide—leprosy	0.00151	0.00579	CcSEcCtD
Rizatriptan—Tremor—Thalidomide—leprosy	0.0015	0.00575	CcSEcCtD
Rizatriptan—Agitation—Thalidomide—leprosy	0.00147	0.00564	CcSEcCtD
Rizatriptan—Angioedema—Thalidomide—leprosy	0.00146	0.00561	CcSEcCtD
Rizatriptan—Vertigo—Thalidomide—leprosy	0.00144	0.00552	CcSEcCtD
Rizatriptan—Syncope—Thalidomide—leprosy	0.00144	0.00551	CcSEcCtD
Rizatriptan—Palpitations—Thalidomide—leprosy	0.00142	0.00543	CcSEcCtD
Rizatriptan—Loss of consciousness—Thalidomide—leprosy	0.00141	0.0054	CcSEcCtD
Rizatriptan—Cough—Thalidomide—leprosy	0.0014	0.00536	CcSEcCtD
Rizatriptan—Convulsion—Thalidomide—leprosy	0.00139	0.00532	CcSEcCtD
Rizatriptan—Hypertension—Thalidomide—leprosy	0.00138	0.0053	CcSEcCtD
Rizatriptan—Myalgia—Thalidomide—leprosy	0.00136	0.00523	CcSEcCtD
Rizatriptan—Chest pain—Thalidomide—leprosy	0.00136	0.00523	CcSEcCtD
Rizatriptan—Arthralgia—Thalidomide—leprosy	0.00136	0.00523	CcSEcCtD
Rizatriptan—Anxiety—Thalidomide—leprosy	0.00136	0.00521	CcSEcCtD
Rizatriptan—Discomfort—Thalidomide—leprosy	0.00135	0.00517	CcSEcCtD
Rizatriptan—Dry mouth—Thalidomide—leprosy	0.00133	0.00511	CcSEcCtD
Rizatriptan—Confusional state—Thalidomide—leprosy	0.00132	0.00505	CcSEcCtD
Rizatriptan—Oedema—Thalidomide—leprosy	0.00131	0.00501	CcSEcCtD
Rizatriptan—Shock—Thalidomide—leprosy	0.00129	0.00493	CcSEcCtD
Rizatriptan—Nervous system disorder—Thalidomide—leprosy	0.00128	0.00492	CcSEcCtD
Rizatriptan—Tachycardia—Thalidomide—leprosy	0.00128	0.00489	CcSEcCtD
Rizatriptan—Hyperhidrosis—Thalidomide—leprosy	0.00126	0.00485	CcSEcCtD
Rizatriptan—Anorexia—Thalidomide—leprosy	0.00125	0.00478	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Thalidomide—leprosy	0.00119	0.00457	CcSEcCtD
Rizatriptan—Insomnia—Thalidomide—leprosy	0.00118	0.00453	CcSEcCtD
Rizatriptan—Paraesthesia—Thalidomide—leprosy	0.00117	0.0045	CcSEcCtD
Rizatriptan—Dyspnoea—Thalidomide—leprosy	0.00117	0.00447	CcSEcCtD
Rizatriptan—Somnolence—Thalidomide—leprosy	0.00116	0.00446	CcSEcCtD
Rizatriptan—Dyspepsia—Thalidomide—leprosy	0.00115	0.00441	CcSEcCtD
Rizatriptan—Decreased appetite—Thalidomide—leprosy	0.00114	0.00436	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Thalidomide—leprosy	0.00113	0.00433	CcSEcCtD
Rizatriptan—Fatigue—Thalidomide—leprosy	0.00113	0.00432	CcSEcCtD
Rizatriptan—Constipation—Thalidomide—leprosy	0.00112	0.00429	CcSEcCtD
Rizatriptan—Pain—Thalidomide—leprosy	0.00112	0.00429	CcSEcCtD
Rizatriptan—Feeling abnormal—Thalidomide—leprosy	0.00108	0.00413	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Thalidomide—leprosy	0.00107	0.0041	CcSEcCtD
Rizatriptan—Urticaria—Thalidomide—leprosy	0.00104	0.00398	CcSEcCtD
Rizatriptan—Body temperature increased—Thalidomide—leprosy	0.00103	0.00396	CcSEcCtD
Rizatriptan—Abdominal pain—Thalidomide—leprosy	0.00103	0.00396	CcSEcCtD
Rizatriptan—Hypersensitivity—Thalidomide—leprosy	0.000964	0.00369	CcSEcCtD
Rizatriptan—Asthenia—Thalidomide—leprosy	0.000939	0.0036	CcSEcCtD
Rizatriptan—Pruritus—Thalidomide—leprosy	0.000926	0.00355	CcSEcCtD
Rizatriptan—Diarrhoea—Thalidomide—leprosy	0.000895	0.00343	CcSEcCtD
Rizatriptan—Dizziness—Thalidomide—leprosy	0.000865	0.00332	CcSEcCtD
Rizatriptan—Vomiting—Thalidomide—leprosy	0.000832	0.00319	CcSEcCtD
Rizatriptan—Rash—Thalidomide—leprosy	0.000825	0.00316	CcSEcCtD
Rizatriptan—Dermatitis—Thalidomide—leprosy	0.000824	0.00316	CcSEcCtD
Rizatriptan—Headache—Thalidomide—leprosy	0.00082	0.00314	CcSEcCtD
Rizatriptan—Nausea—Thalidomide—leprosy	0.000777	0.00298	CcSEcCtD
